These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 35099393)

  • 1. Using Electronic Health Records for Personalized Dosing of Intravenous Vancomycin in Critically Ill Neonates: Model and Web-Based Interface Development Study.
    Hui KHM; Lam HS; Chow CHT; Li YSJ; Leung PHT; Chan LYB; Lee CP; Ewig CLY; Cheung YT; Lam TNT
    JMIR Med Inform; 2022 Jan; 10(1):e29458. PubMed ID: 35099393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcus.
    Chung E; Seto W
    Pharmacotherapy; 2023 Dec; 43(12):1262-1276. PubMed ID: 37574774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
    Rao Z; Guo SM; Wei YM
    Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-center prospective population pharmacokinetic study and the performance of web-based individual dose optimization application of intravenous vancomycin for adults in Hong Kong: A study protocol.
    Hui KHM; Lui CYG; Wu KLA; Chen J; Cheung YT; Lam TNT
    PLoS One; 2022; 17(5):e0267894. PubMed ID: 35511796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiologically Based Pharmacokinetic Modeling of Vancomycin and its Comparison with Population Pharmacokinetic Model in Neonates.
    Cao A; Li Q; Han M; Liu Q; Liang H; Tan L; Guan Y
    J Clin Pharmacol; 2024 Sep; ():. PubMed ID: 39223982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between vancomycin trough concentration and area under the concentration-time curve in neonates.
    Frymoyer A; Hersh AL; El-Komy MH; Gaskari S; Su F; Drover DR; Van Meurs K
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6454-61. PubMed ID: 25136027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and dose optimization of vancomycin in neonates.
    Lee SM; Yang S; Kang S; Chang MJ
    Sci Rep; 2021 Mar; 11(1):6168. PubMed ID: 33731764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of vancomycin in very low birth weight neonates.
    Alsultan A; Al Munjem MF; Atiq KM; Aljehani ZK; Al Muqati H; Almohaizeie A; Ballal DA; Refaei TM; Al Jeraisy M; Assiri A; Abouelkheir M
    Front Pediatr; 2023; 11():1093171. PubMed ID: 37063687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Vancomycin Dosing and Monitoring in Neonates and Infants Using Population Pharmacokinetic Modeling.
    Jarugula P; Akcan-Arikan A; Munoz-Rivas F; Moffett BS; Ivaturi V; Rios D
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0189921. PubMed ID: 35293782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin is commonly under-dosed in critically ill children and neonates.
    Sosnin N; Curtis N; Cranswick N; Chiletti R; Gwee A
    Br J Clin Pharmacol; 2019 Nov; 85(11):2591-2598. PubMed ID: 31378957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and individualized dosing of vancomycin for critically ill patients receiving continuous renal replacement therapy: the role of residual diuresis.
    Yu Z; Liu J; Yu H; Zhou L; Zhu J; Liang G; Yang Y; Zheng Y; Han Y; Xu J; Han G; Yu L; Zhao Y
    Front Pharmacol; 2023; 14():1298397. PubMed ID: 38223197
    [No Abstract]   [Full Text] [Related]  

  • 13. First-Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area-Under-the-Curve Target Attainment in Critically Ill Patients.
    Flannery AH; Delozier NL; Effoe SA; Wallace KL; Cook AM; Burgess DS
    Pharmacotherapy; 2020 Dec; 40(12):1210-1218. PubMed ID: 33176005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
    Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
    Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous haemodiafiltration (CVVHDF).
    Kirwan M; Munshi R; O'Keeffe H; Judge C; Coyle M; Deasy E; Kelly YP; Lavin PJ; Donnelly M; D'Arcy DM
    Crit Care; 2021 Dec; 25(1):443. PubMed ID: 34930430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
    Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
    Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin Prescribing Practices and Therapeutic Drug Monitoring for Critically Ill Neonatal and Pediatric Patients: A Survey of Physicians and Pharmacists in Hong Kong.
    Chow TCH; Li JYS; Wong JCL; Poon FMH; Lam HS; Lam TT; Lee CP; Ewig CL; Cheung YT
    Front Pediatr; 2020; 8():538298. PubMed ID: 33330263
    [No Abstract]   [Full Text] [Related]  

  • 18. Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations.
    Li ZL; Liu YX; Jiao Z; Qiu G; Huang JQ; Xiao YB; Wu SJ; Wang CY; Hu WJ; Sun HJ
    Front Pharmacol; 2018; 9():603. PubMed ID: 29997498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates.
    Leroux S; Biran V; van den Anker J; Gotta V; Zhao W; Zhang D; Jacqz-Aigrain E; Pfister M
    Front Pharmacol; 2021; 12():634686. PubMed ID: 33967770
    [No Abstract]   [Full Text] [Related]  

  • 20. External Validation of Model-Based Dosing Guidelines for Vancomycin, Gentamicin, and Tobramycin in Critically Ill Neonates and Children: A Pragmatic Two-Center Study.
    Hartman SJF; Orriëns LB; Zwaag SM; Poel T; de Hoop M; de Wildt SN
    Paediatr Drugs; 2020 Aug; 22(4):433-444. PubMed ID: 32507958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.